Umbralisib
Back to searchMolecule Structure
Scientific Name
Umbralisib
Description of the Drug
Umbralisib is a kinase inhibitor used to treat rare forms of refractory lymphoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14989
http://www.drugbank.ca/drugs/DB14989
Brand Name(s)
Not Available
Company Owner(s)
Tg Therapeutics Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Tyrosine-protein kinase ABL | SINGLE PROTEIN | INHIBITOR | CHEMBL1862 |
Casein kinase I epsilon | SINGLE PROTEIN | INHIBITOR | CHEMBL4937 |
PI3-kinase p110-delta subunit | SINGLE PROTEIN | INHIBITOR | CHEMBL3130 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL15557416 |
Human Metabolome Database | HMDB0304848 |
DrugBank | DB14989 |
PubChem | 72950888 |
BindingDB | 184556 |
DrugCentral | 5441 |
ChemicalBook | CB62716383 |
Guide to Pharmacology | 8916 |
ZINC | ZINC000141831516 |